Aspirin may be the most common anti-platelet agent in use, but is it the safest? For decades, Aspirin has been used prophylactically, yet research is starting to show that there is no place for aspirin in stroke prevention. Navigating the minefield of anti-platelet agents can be confusing, and keeping up with current research can be hard. So let Dr Jenny Gowan guide you through the latest information on anti-platelets, and allow her to dissolve your confusion.
Jenny, a practising pharmacist, is a teaching associate at Monash University, Melbourne and a clinical associate of RMIT University. She is a member of the PSA Branch committee, the Expert Group for Therapeutic Guidelines – Respiratory version 5, an editorial board member of AUS-DI, SHPA "Don’t Rush to Crush", the Guidelines Committee for the Australian Asthma Handbook (AAH) and the writing group for the RACGP ‘Medical Care of older persons in RACF’ (Silver book). Jenny is an accredited consultant pharmacist who conducts her own company, which focuses on medication reviews in the home and aged care facilities, plus education, writing, training, and consultation. Jenny works regularly in community pharmacy plus sessions in a GP clinic at a Community Health Centre. She has published over 400 educational articles. Jenny has presented talks at many Australian and international conferences to GPs, nurse practitioners, nurses, podiatrists, pharmacists, and other health professionals. In 2013, she was awarded the Australian Pharmacist of the Year by the Pharmaceutical Society of Australia and, in 2016, the AACP-MIMs Australian Consultant Pharmacist of the Year.